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Background: We evaluated the combined use of the modified Hodge test (MHT) and car-
bapenemase inhibition test (CIT) using phenylboronic acid (PBA) and EDTA to detect car-
bapenemase-producing Enterobacteriaceae (CPE) and metallo-β-lactamase (MBL)-pro-
ducing Pseudomonas spp.
Methods: A total of 49 isolates of CPE (15 Klebsiella pneumoniae carbapenemase [KPC], 5 
Guiana extended-spectrum β-lactamase [GES]-5, 9 New Delhi metallo-β-lactamase [NDM]-
1, 5 Verona integron-encoded metallo-β-lactamase [VIM]-2, 3 imipenem-hydrolyzing 
β-lactamase [IMP], and 12 oxacillinase [OXA]-48-like), 25 isolates of MBL-producing Pseu-
domonas spp. (14 VIM-2 and 11 IMP), and 35 carbapenemase-negative controls were in-
cluded. The MHT was performed for all isolates as recommended by the Clinical and Labo-
ratory Standards Institute. Enhanced growth of the indicator strain was measured in mm 
with a ruler. The CIT was performed by directly dripping PBA and EDTA solutions onto car-
bapenem disks that were placed on Mueller-Hinton agar plates seeded with the test strain.
Results: Considering the results of the MHT with the ertapenem disk in Enterobacteriaceae 
and Pseudomonas spp., the CIT with the meropenem disk in Enterobacteriaceae, and the 
imipenem disk in Pseudomonas spp., three combined disk tests, namely MHT-positive 
plus PBA-positive, EDTA-positive, and MHT-positive plus PBA-negative plus EDTA-nega-
tive, had excellent sensitivity and specificity for the detection of KPC- (100% sensitivity and 
100% specificity), MBL- (94% sensitivity and 100% specificity), and OXA-48-like-produc-
ing isolates (100% sensitivity and 100% specificity), respectively.
Conclusions: Combined use of the MHT and CIT with PBA and EDTA, for the detection of 
CPE and MBL-producing Pseudomonas spp., is effective in detecting and characterizing 
carbapenemases in routine laboratories.
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INTRODUCTION
The global spread of carbapenemase-producing gram-negative 
bacilli in the last decade is a serious health threat, and limited 
treatment options are available for such infections [1]. Rapid and 
accurate detection of resistance mechanisms is essential for de-
termining appropriate antimicrobial therapy and infection control 
measures. 
 Several tests have been developed for the phenotypic detec-
tion of carbapenemases [2-4]. The modified Hodge test (MHT) 
is inexpensive and feasible for practically all clinical laboratories. 
The MHT is a CLSI-recommended phenotypic method for car-
bapenemase detection. This recommended method detects car-
bapenemase in Enterobacteriaceae isolates but not in Pseudo-
monas spp. Although the MHT often has high sensitivity [5-7], 
its interpretation is often difficult and subjective [8, 9]. Moreover, 
many studies have demonstrated false-positive results in the 
presence of extended-spectrum β-lactamases (ESBLs) and 
AmpC β-lactamases [10, 11]. The carbapenemase inhibition 
test (CIT) uses β-lactamase inhibitors, including boronic acid 
compounds, EDTA, dipicolinic acid (DPA), and cloxacillin (CLX) 
to differentiate class A carbapenemases from class B and class 
D carbapenemases [12-14]. 
 In this study, we evaluated the combined use of the MHT and 
the CIT to more effectively detect carbapenemase-producing 
Enterobacteriaceae (CPE) and metallo-β-lactamase (MBL)-pro-
ducing-Pseudomonas spp.
METHODS
1. Bacterial isolates
Sixty-three Enterobacteriaceae and 46 Pseudomonas spp. were 
used in this study; these carbapenem-non-susceptible isolates 
were obtained from clinical sources (Tables 1, 2). The species 
were identified by using the Vitek 2 system (bioMerieux Vitek 
Inc., Hazelwood, MO, USA). A total of 49 isolates of CPE (Klebsi-
ella pneumoniae carbapenemase [KPC] [n=15], Guiana ex-
tended-spectrum β-lactamase [GES]-5 [n =5], New Delhi 
metallo-β-lactamase [NDM]-1 [n=9], Verona integron-encoded 
metallo-β-lactamase [VIM]-2 [n =5], imipenem-hydrolyzing 
β-lactamase [IMP] [n =3], and oxacillinase (OXA)-48-like 
[n=12]) and 25 isolates of MBL-producing Pseudomonas spp. 
(VIM-2 [n=14] and IMP [n=11]) were included. The remaining 
35 carbapenemase-negative controls were AmpC β-lactamase-
producing Enterobacteriaceae with porin loss (n=14) and Pseu-
domonas aeruginosa overexpressing AmpC β-lactamases 
(n=21). These β-lactamases were characterized by PCR and 
DNA sequencing [15-18]. Porin loss was detected as previously 
described [19]. The minimum inhibitory concentrations (MICs) 
of imipenem (IPM), meropenem (MEM), and ertapenem (ETP) 
were determined by Etest (bioMerieux, Marcy l’Etoile, France) 
and interpreted according to CLSI breakpoints, as updated in 
2013 [20]. 
2. Modified Hodge test 
The MHT was performed for all isolates as recommended by 
CLSI [20]. ETP disks were placed on Mueller-Hinton agar (MHA) 
(Becton-Dickinson, Cockeysville, MD, USA) plates seeded with 
Escherichia coli ATCC 25922. The isolates were inoculated in a 
straight line from the edge of the disk to the edge of the plate. 
The plates were incubated at 35°C for 16-20 hr. Enhanced 
growth of the indicator strain was measured in mm with a ruler. 
The length of the straight line from the enhanced growth ob-
tained from the isolate to the end of inhibition zone was classified 
as negative (<2 mm), weakly positive (2-3 mm), and positive (≥ 
4 mm). When a clear area was observed around the streak, the 
MHT result was considered indeterminate.
3. Carbapenemase inhibition test 
The two different β-lactamase inhibitors were 30 mg/mL phenyl-
boronic acid (PBA) (Sigma-Aldrich, St. Louis, MO, USA) solution 
and 30 mg/mL EDTA (Sigma-Aldrich) solution. PBA and EDTA 
were dissolved in dimethylsulfoxide and sterile water, respectively. 
A 0.5 McFarland inoculum of the organisms was prepared and 
spread on each MHA plate (Becton-Dickinson). Three ETP, IPM, 
and MEM disks were placed in rows on the MHA plate seeded 
with the test strain. Then, 10 µL of EDTA and 10 µL of PBA were 
added to the first and third disks, respectively (Fig. 1). A differ-
ence of ≥5 mm in zone diameter (around the disks) between the 
disks containing the PBA and EDTA solutions and that containing 
carbapenems alone was considered positive for PBA and EDTA, 
whereas an increase of <5 mm was considered negative. 
 The stability of the in-laboratory-prepared PBA and EDTA solu-
tions, stored at 0°C, was tested twice weekly for 5 weeks by us-
ing 5 controls: KPC-2-producing Klebsiella pneumoniae, NDM-
1-producing K. pneumoniae, VIM-2-producing P. aeruginosa, 
IMP-6-producing P. aeruginosa, OXA-232-producing K. pneu-
moniae, and DHA-1-producing K. pneumoniae with porin loss.
4. Sensitivity and specificity 
The performance of the tests for the detection of carbapene-
mases was determined by using genotypically defined car-
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Table 1. Evaluation of the MHT and CIT for the detection of carbapenemase-producing isolates of carbapenem-non-susceptible Enterobac-
teriaceae 
No. Organism
Carbapene-
mase
Result
in
MHT
Increase in zone diameter (mm) around carbapenem disks 
containing β-lactamase inhibitors
MIC (µg/mL) of:
IPM plus: MEM plus: ETP plus:
IPM MEM ETP
PBA EDTA PBA EDTA PBA EDTA
1 K. pneumoniae KPC-2 + 5* -2 7 2 6 0 4 4 16
2 K. pneumoniae KPC-2 + 4 0 10 2 6 0 4 4 16
3 K. pneumoniae KPC-2 + 3 -1 6 0 7 1 8 8 16
4 K. pneumoniae KPC-2 + 4 0 7 2 6 1 16 16 16
5 K. pneumoniae KPC-2 + 6 0 8 0 8 2 4 2 8
6 K. pneumoniae KPC-2 + 6 1 7 1 8 1 4 8 8
7 K. pneumoniae KPC-2 + 5 0 7 0 8 0 16 16 16
8 K. pneumoniae KPC-2 + 3 1 7 1 5 1 4 2 8
9 K. pneumoniae KPC-2 + 4 0 7 1 7 1 16 16 16
10 K. pneumoniae KPC-3 + 5 0 6 1 7 0 16 16 16
11 K. pneumoniae KPC-3 + 4 0 7 1 6 0 8 4 4
12 K. pneumoniae KPC-3 + 6 0 8 1 7 0 8 8 8
13 K. pneumoniae KPC-3 + 2 0 8 2 8 0 8 16 16
14 K. pneumoniae KPC-3 + 4 1 7 2 5 0 8 8 8
15 K. pneumoniae KPC-3 + 5 0 7 1 7 0 8 16 8
16 K. pneumoniae NDM-1 +/- 0 3 0 6 1 7 2 2 16
17 K. pneumoniae NDM-1 + 0 7 0 14 -2 12 16 16 >32
18 K. pneumoniae NDM-1 + -1 7 -3 13 0 13 16 32 >32
19 K. pneumoniae NDM-1 + 0 18 0 13 0 10 >32 >32 >32
20 K. pneumoniae NDM-1 +/- 1 15 0 11 0 6 >32 >32 >32
21 K. pneumoniae NDM-1 +/- 0 14 0 11 0 6 >32 >32 >32
22 K. pneumoniae NDM-1 + 1 7 1 12 0 12 2 8 >32
23 K. pneumoniae NDM-1 + 0 7 0 11 0 12 2 4 32
24 K. pneumoniae NDM-1 + 0 14 0 11 0 8 >32 >32 >32
25 E. cloacae VIM-2 + 0 5 2 7 4 2 32 16 32
26 E. cloacae VIM-2 + 3 5 4 4 4 1 8 4 >32
27 S. marcescens VIM-2 + 4 12 2 15 0 3 >32 >32 >32
28 C. freundii VIM-2 + 0 4 2 7 2 5 2 1 2
29 C. freundii VIM-2 + 0 4 0 6 1 6 1 0.5 2
30 K. pneumoniae IMP-6 + 1 1 -1 5 0 5 2 2 2
31 K. pneumoniae IMP-6 + 0 2 0 6 1 4 2 2 2
32 E. cloacae IMP-6 + 0 3 -1 6 0 8 2 4 8
33 K. pneumoniae OXA-48 + 1 1 0 0 1 1 1 0.5 2
34 K. pneumoniae OXA-181 + 0 2 2 3 6 5 0.5 0.5 4
35 K. pneumoniae OXA-232 + 0 2 0 2 0 2 4 32 >32
36 K. pneumoniae OXA-232 + 1 1 1 1 1 0 4 16 >32
37 K. pneumoniae OXA-232 + 1 0 2 2 0 1 2 8 >32
(Continued to the next page)
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bapenemase mechanisms as the reference standard. Sensitivity 
was calculated from the number of true-positive isolates, 
whereas specificity was calculated from the number of true-
negative isolates.
RESULTS
1. Modified Hodge test  
The MHTs were positive for all CPEs, except five GES-5-produc-
ing K. pneumoniae isolates. Tests for all non-CPE isolates were 
negative, other than two K. pneumoniae and two Serratia marc-
escens isolates that showed weak positive results (Table 1). 
Nineteen out of 25 MBL-producing Pseudomonas spp. showed 
positive results, and all non-carbapenemase-producing Pseudo-
monas spp. showed negative (n=15) or indeterminate (n=3) 
results (Table 2).
No. Organism
Carbapene-
mase
Result
in
MHT
Increase in zone diameter (mm) around carbapenem disks 
containing β-lactamase inhibitors
MIC (µg/mL) of:
IPM plus: MEM plus: ETP plus:
IPM MEM ETP
PBA EDTA PBA EDTA PBA EDTA
38 K. pneumoniae OXA-232 + 0 0 0 0 1 0 2 8 >32
39 K. pneumoniae OXA-232 + 1 1 0 0 0 0 2 16 >32
40 K. pneumoniae OXA-232 + 2 0 0 0 1 0 4 16 >32
41 K. pneumoniae OXA-232 + 0 -1 1 1 1 0 8 16 >32
42 E. coli OXA-232 + 0 0 0 1 2 1 0.25 0.25 4
43 E. coli OXA-232 + 0 0 0 0 0 0 0.5 1 16
44 E. coli OXA-232 + 0 0 2 0 2 1 2 4 32
45 K. pneumoniae GES-5 - 0 1 4 1 3 1 1 4 32
46 K. pneumoniae GES-5 - 4 2 4 0 4 1 0.25 0.125 1
47 K. pneumoniae GES-5 - 2 2 4 0 4 1 1 4 8
48 K. pneumoniae GES-5 - 0 2 2 2 2 2 0.25 0.125 1
49 K. pneumoniae GES-5 - 0 0 3 0 4 0 1 4 16
50 K. pneumoniae None - 2 2 3 2 4 4 1 4 >32
51 K. pneumoniae None - 2 2 2 3 2 3 1 4 >32
52 K. pneumoniae None +/- 0 2 0 0 2 2 0.25 0.25 2
53 K. pneumoniae None - 0 0 2 1 5 7 1 4 >32
54 K. pneumoniae None - 0 0 4 3 4 2 1 4 >32
55 K. pneumoniae None +/- 10 1 12 4 9 2 32 16 >32
56 K. pneumoniae None - 10 1 9 1 9 1 >32 32 >32
57 K. pneumoniae None - 10 2 5 0 11 3 >32 8 >32
58 S. marcescens None +/- 0 -2 4 2 10 5 0.25 1 4
59 S. marcescens None +/- 2 0 6 2 12 3 4 8 >32
60 S. marcescens None - 2 2 4 2 8 2 8 8 >32
61 S. marcescens None - 0 0 1 1 2 2 2 0.5 1
62 E. cloacae None - 0 1 2 2 2 0 0.25 0.125 1
63 E. aerogenes None - 0 0 2 0 4 -1 0.25 0.125 1
 *Underlined values are considered positive.
Abbreviations: MHT, modified Hodge test; CIT, carbapenemase inhibition test; MIC, minimum inhibitory concentration; IPM, imipenem; MEM, meropenem; 
ETP, ertapenem; PBA, phenylboronic acid; KPC, Klebsiella pneumoniae carbapenemase; NDM, New Delhi metallo-β-lactamase; VIM, Verona integron-en-
coded metallo-β-lactamase; IMP, imipenem-hydrolyzing β-lactamase; OXA, oxacillinase; GES, Guiana extended-spectrum β-lactamase. 
Table 1. Continued
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Table 2. Evaluation of the MHT and CIT for the detection of MBL-producing isolates of carbapenem-non-susceptible Pseudomonas spp.
No. Organism MBL
Result
in
MHT
Increase in zone diameter (mm) around carbapenem disks containing 
β-lactamase inhibitors
MIC (µg/mL) of:
IPM plus: MEM plus: ETP plus:
IPM MEM
PBA EDTA PBA EDTA PBA EDTA
1 P. aeruginosa VIM-2 - 0 10* 0 7 0 2 >32 >32
2 P. aeruginosa VIM-2 - 0 9 0 6 0 3 >32 >32
3 P. aeruginosa VIM-2 - 0 10 0 6 0 2 >32 >32
4 P. aeruginosa VIM-2 + 1 17 1 12 0 4 32 16
5 P. aeruginosa VIM-2 + 0 13 0 3 0 1 >32 >32
6 P. aeruginosa VIM-2 + 0 12 0 3 0 1 >32 >32
7 P. aeruginosa VIM-2 +/- 0 5 0 2 0 1 >32 >32
8 P. aeruginosa VIM-2 + 2 13 3 10 4 8 16 8
9 P. aeruginosa VIM-2 + 1 18 4 15 2 4 16 16
10 P. aeruginosa VIM-2 + 1 11 1 11 2 7 8 4
11 P. aeruginosa VIM-2 - 0 12 2 12 2 12 8 4
12 P. putida VIM-2 - 0 16 0 2 0 2 >32 >32
13 P. putida VIM-2 - 2 16 0 12 0 7 >32 >32
14 P. putida VIM-2 + 0 17 0 3 0 2 >32 >32
15 P. aeruginosa IMP-6 + 1 6 0 0 0 0 >32 >32
16 P. aeruginosa IMP-6 + -1 9 0 0 0 0 >32 >32
17 P. aeruginosa IMP-26 + 6 17 0 11 0 4 16 >32
18 P. aeruginosa IMP-6 + 2 5 0 0 0 0 >32 >32
19 P. aeruginosa IMP-6 + 0 6 0 0 0 0 >32 >32
20 P. aeruginosa IMP-6 + 1 6 0 1 0 0 32 >32
21 P. aeruginosa IMP-6 + 3 10 0 1 0 1 >32 >32
22 P. aeruginosa IMP-6 + 1 10 0 1 0 0 >32 >32
23 P. aeruginosa IMP-6 + 3 7 0 1 0 0 32 >32
24 P. aeruginosa IMP-6 + 0 7 0 0 0 1 8 >32
25 P. aeruginosa IMP-6 + 2 7 0 2 0 1 16 >32
26 P. aeruginosa None - 14 1 0 3 0 1 >32 >32
27 P. aeruginosa None - 15 2 0 3 0 1 >32 >32
28 P. aeruginosa None - 15 3 3 4 0 0 >32 >32
29 P. aeruginosa None - 18 2 4 3 0 1 >32 >32
30 P. aeruginosa None ind 13 1 0 1 0 0 32 >32
31 P. aeruginosa None - 16 3 0 2 0 1 >32 >32
32 P. aeruginosa None - 16 3 0 2 0 1 >32 >32
33 P. aeruginosa None - 17 3 0 3 0 1 >32 >32
34 P. aeruginosa None - 16 3 4 2 0 1 >32 >32
35 P. aeruginosa None - 16 3 2 3 0 2 >32 >32
36 P. aeruginosa None - 15 3 0 2 0 1 >32 >32
37 P. aeruginosa None - 15 3 2 3 0 2 >32 >32
38 P. aeruginosa None - 16 3 0 0 0 0 16 >32
39 P. aeruginosa None ind 14 3 0 0 0 0 16 >32
40 P. aeruginosa None - 15 3 3 3 0 1 >32 >32
41 P. aeruginosa None - 15 3 3 0 0 0 >32 >32
42 P. aeruginosa None - 16 3 4 1 0 0 >32 >32
43 P. aeruginosa None ind 17 3 0 2 0 1 >32 >32
44 P. aeruginosa None - 18 3 3 2 0 0 >32 >32
45 P. aeruginosa None - 15 2 0 2 0 0 >32 >32
46 P. aeruginosa None - 16 1 2 2 0 1 16 32
*Underlined values are considered positive.
Abbreviations: MHT, modified Hodge test; CIT, carbapenemase inhibition test; MBL, metallo-β-lactamase; MIC, minimum inhibitory concentration; IPM, imi-
penem; MEM, meropenem; ETP, ertapenem; PBA, phenylboronic acid; VIM, Verona integron-encoded metallo-β-lactamase; IMP, imipenem-hydrolyzing 
β-lactamase. 
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Table 3. Sensitivity and specificity of MHT for ertapenem disks, CIT for meropenem disks in Enterobacteriaceae and imipenem disks in 
Pseudomonas spp.  
Test results
Carbapenemase 
targeted
Enterobacteriaceae Pseudomonas spp.
Sensitivity (%) Specificity (%) Sensitivity (%) Specificity (%)
MHT-positive plus PBA-positive KPC* 100 100 NA NA
EDTA-positive MBL† 94 100 100 100
MHT-positive plus PBA-negative plus EDTA-negative OXA-48‡ 100 100 NA NA
*KPC includes KPC-2 and -3; †MBL includes VIM-2, IMP-6, IMP-26, and NDM-1; ‡OXA-48 includes OXA-48, OXA-181, and OXA-232.
Abbreviations: MHT, modified Hodge test; CIT, carbapenemase inhibition test; PBA, phenylboronic acid; MBL, metallo-β-lactamase; NA, not available.
Fig. 1. Representative CIT results for the KPC-2-producing K. pneumoniae isolate (A) and IMP-6-producing P. aeruginosa isolate (B) are 
shown. Three horizontal lines of disks containing 3 ETP, 3 IPM, and 3 MEM were placed on a MHA plate seeded with the test strain. Then, 
10 µL of EDTA (30 mg/mL) and PBA (30 mg/mL) were added along first and third vertical lines, respectively. (A) The difference in zone size 
in the presence and absence of PBA was ≥5 mm for ETP, IPM, and MEM, suggesting KPC production. (B) The difference in zone size in 
the presence and absence of EDTA was ≥5 mm for IPM, suggesting MBL production. 
Abbreviations: CIT, carbapenemase inhibition test; ETP, ertapenem; IPM, imipenem; MEM, meropenem; PBA, phenylboronic acid; KPC, K. pneumoniae 
carbapenemase; MBL, metallo-β-lactamase.
A B
EDTA EDTAPBA PBA
2. Carbapenemase inhibition test 
All KPC-producing Enterobacteriaceae using MEM disks sup-
plemented with PBA (MEM-PBA) tested positive. All MBL-pro-
ducing Enterobacteriaceae were MEM-EDTA-positive except 
one isolate of VIM-2-producing Enterobacter cloacae. All OXA-
48-like- and GES-5-producing Enterobacteriaceae were MEM-
PBA-and MEM-EDTA-negative. Four of 14 non-CPE isolates 
were MEM-PBA-positive (Table 1). All MBL- and non-carbapen-
emase-producing Pseudomonas spp. were IPM-EDTA- and 
IPM-PBA-positive, respectively (Table 2). 
 The activities of PBA and EDTA solutions at week 1 were 
compared with those of freshly made solutions. Similar inhibi-
tion zones were observed for all carbapenemase-inhibitor com-
binations during the 5-week study period, indicating that these 
solutions can be prepared and kept at 0°C without losing activity 
(data not shown).
3.  Sensitivity and specificity in the combined interpretation 
of MHT and CIT
We performed the MHT using ETP to screen for Enterobacteria-
ceae and Pseudomonas spp. and the CIT using MEM and IPM 
to screen for Enterobacteriaceae and Pseudomonas spp., re-
spectively. The combined disk tests that were MHT-positive (≥4 
mm) plus PBA-positive (≥5 mm), EDTA-positive (≥5 mm), and 
MHT-positive plus PBA-negative plus EDTA-negative, had excel-
lent sensitivity and specificity for the detection of KPC- (100% 
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sensitivity and 100% specificity), MBL- (94% sensitivity and 
100% specificity), and OXA-48-like-producing isolates (100% 
sensitivity and 100% specificity), respectively (Table 3).
DISCUSSION
The MHT is highly sensitive and suitable for the screening of 
carbapenemase production. However, its results are often diffi-
cult to interpret, and false-positive results are observed for 
strains producing ESBL or AmpC β-lactamase-with porin loss [6, 
7]. Furthermore, it may be difficult for laboratories lacking expe-
rience to interpret the results, because of the subjective nature 
of the MHT [8, 9]. To interpret the results of the MHT objectively, 
we established quantitative criteria. The MHT with E. coli ATCC 
25922 as an indicator strain previously displayed a higher per-
centage of indeterminate results (32%) in P. aeruginosa [21] 
than the 6.5% of indeterminate results in Pseudomonas spp. 
reported in our study.
 To discriminate between the classes of carbapenemases, var-
ious CITs are commonly used, including the combined disk test 
(disk potentiation test) and the double disk synergy test (double 
disk potentiation test) [22, 23]. We used the combined disk test 
for carbapenem-non-susceptible strains. The CIT uses mostly 
dried carbapenem disks containing carbapenemase inhibitors, 
such as boronic acid, CLX, and DPA or EDTA. However, we se-
lected the CIT that involved directly dripping the PBA and EDTA 
solutions onto carbapenem disks placed on MHA plates seeded 
with the test strain. This method was easier to carry out than the 
CIT using dried disks in routine laboratories. MEM and IPM disks 
were most effective for the detection of CPE and MBL-produc-
ing Pseudomonas spp., respectively. In a previous study, the 
sensitivity of IPM-DPA disks (97.7%) was higher than that of 
MEM-DPA disks (79.5%) for MBL-producing Pseudomonas 
spp. [24]. DPA has excellent sensitivity and specificity for the 
detection of MBL-producing K. pneumoniae, but the poorer 
specificity of EDTA calls into question the usefulness of this in-
hibitor [14]. In this study, DPA was stable for a shorter time than 
EDTA, at 2 weeks and 5 weeks, respectively (data not shown). 
Hence, we used EDTA for the detection of the MBL-producing 
isolates. 
 In our study, all isolates of KPC-producing Enterobacteriaceae 
were MEM-PBA-positive. Four of the 14 non-CPE isolates were 
weakly positive in MHT, but none of them were positive in MHT. 
It is unclear why the GES-5-producing K. pneumoniae isolates 
showed negative results for MHT and MEM-PBA. Unfortunately, 
these methods could not detect GES-5 class A carbapene-
mases. Many isolates with AmpC β-lactamase hyperproduction 
were both PBA-positive and CLX-positive [14]. The CIT using 
CLX was also needed to discriminate between KPC and AmpC 
β-lactamase. However, the combined use of the MHT and CIT 
using MEM-PBA discriminated between Enterobacteriaceae 
that produced KPC and AmpC β-lactamase. We observed 
weakly positive MHT results for three of nine NDM-1-producing 
K. pneumoniae isolates, but all MBL-producing Enterobacteria-
ceae isolates were MEM-EDTA-positive, regardless of the MHT 
results. Although there are no known specific inhibitors for class 
D carbapenemases, the combined use of the MHT and CIT us-
ing MEM-PBA and MEM-EDTA enabled the detection of all OXA-
48-like-producing Enterobacteriaceae.
 False-negative results of the MHT were reported for six of the 
14 VIM-2-producing Pseudomonas spp., but all isolates of 
MBL-producing Pseudomonas spp. were IPM-EDTA-positive, 
regardless of the MHT results. All non-carbapenemase-produc-
ing Pseudomonas spp. exhibited negative MHT results but were 
IPM-PBA-positive, suggesting that the isolates overexpressed 
AmpC β-lactamases.
 In conclusion, we propose a new strategy to detect carbapen-
emase resistance by the combined testing and interpretation of 
the MHT and CIT with PBA and EDTA. The combinations, 
namely MHT-positive (≥4 mm) plus PBA-positive (≥5 mm), 
EDTA-positive (≥5 mm), and MHT-positive plus PBA-negative 
plus EDTA-negative, had excellent sensitivity and specificity for 
the detection of KPC-, MBL-, and OXA-48-producing isolates, 
respectively. This method will facilitate the detection and char-
acterization of carbapenemases in routine laboratories. In this 
study, we could include only a small number of characterized 
isolates, and none of the isolates that coexisted with carbapene-
mase production were examined; hence, further analysis is 
needed to validate these results.
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